Article
Distinct antifibrogenic effects of erlotinib, sunitinib and sorafenib on rat pancreatic stellate cells.
World journal of gastroenterology - 28 Jun 2014
Elsner Anne, Lange Falko, Fitzner Brit, Heuschkel Martin, Krause Bernd Joachim, Jaster Robert
Abstract excerpt
AIM: To study if three clinically available small molecule kinase inhibitors (SMI), erlotinib, sunitinib and sorafenib, exert antifibrogenic effects on pancreatic stellate cells (PSC) and analyze the basis of their action. METHODS: Cultured rat PSC were exposed to SMI. Cell proliferation and viability were assessed employing 5-bromo-2'-deoxyuridine incorporation assay and flow cytometry, respectively....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
